[Influence of biotechnology and genetic engineering in medical therapy].
Stadler
P
P
D020909:Acarbose; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D019380:Anti-HIV Agents / Q000627:therapeutic use; D007611:Aprotinin / Q000627:therapeutic use; D001709:Biotechnology; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005169:Factor VIII / Q000096:biosynthesis; D005818:Genetic Engineering; D015316:Genetic Therapy; D006467:Hemophilia A / Q000628:therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D014312:Trisaccharides / Q000627:therapeutic use
D019380:Anti-HIV Agents; D004791:Enzyme Inhibitors; D007004:Hypoglycemic Agents; D014312:Trisaccharides; D005169:Factor VIII; D007611:Aprotinin; D020909:Acarbose